HCPCS code J2781 — Inj, pegcetacoplan, 1mg. Status: Active. Effective Oct 1, 2023. Source: CMS HCPCS Level II.

J2781

Active

Inj, pegcetacoplan, 1mg

Injection, pegcetacoplan, intravitreal, 1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Oct 1, 2023
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 9158

MUE — Medically Unlikely Edits

Maximum units of J2781 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 30
Practitioner Services 30

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
73606-0020-01 Syfovre

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2023-Q4
    Inj, pegcetacoplan, 1mg